Class information for:
Level 1: CXXC5//THEOPHYLLAMINE//BIOCHIP ARRAY

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
25980 219 40.3 83%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
81 26583 MYELODYSPLASTIC SYNDROMES//ACUTE MYELOID LEUKEMIA//LEUKEMIA

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CXXC5 Author keyword 1 50% 1% 2
2 THEOPHYLLAMINE Author keyword 1 100% 1% 2
3 BIOCHIP ARRAY Author keyword 1 40% 1% 2
4 ACUTE MYELOGENOUS LEUKAEMIA Author keyword 1 10% 3% 7
5 6TG Author keyword 1 50% 0% 1
6 AML BLASTS Author keyword 1 50% 0% 1
7 ASL CASERTA CE Address 1 50% 0% 1
8 CLONAL MYELOID DISEASES Author keyword 1 50% 0% 1
9 COE DEV BIOL REGENERAT MED CEDB DBRM Address 1 50% 0% 1
10 CYTOKINE PANEL Author keyword 1 50% 0% 1

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 CXXC5 1 50% 1% 2 Search CXXC5 Search CXXC5
2 THEOPHYLLAMINE 1 100% 1% 2 Search THEOPHYLLAMINE Search THEOPHYLLAMINE
3 BIOCHIP ARRAY 1 40% 1% 2 Search BIOCHIP+ARRAY Search BIOCHIP+ARRAY
4 ACUTE MYELOGENOUS LEUKAEMIA 1 10% 3% 7 Search ACUTE+MYELOGENOUS+LEUKAEMIA Search ACUTE+MYELOGENOUS+LEUKAEMIA
5 6TG 1 50% 0% 1 Search 6TG Search 6TG
6 AML BLASTS 1 50% 0% 1 Search AML+BLASTS Search AML+BLASTS
7 CLONAL MYELOID DISEASES 1 50% 0% 1 Search CLONAL+MYELOID+DISEASES Search CLONAL+MYELOID+DISEASES
8 CYTOKINE PANEL 1 50% 0% 1 Search CYTOKINE+PANEL Search CYTOKINE+PANEL
9 DEL20 1 50% 0% 1 Search DEL20 Search DEL20
10 EVODIOPANAX INNOVANS 1 50% 0% 1 Search EVODIOPANAX+INNOVANS Search EVODIOPANAX+INNOVANS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AML BLASTS 8 46% 6% 13
2 INCREASE PROLIFERATION 4 67% 2% 4
3 DEFECTIVE INTERLEUKIN 2 PRODUCTION 3 50% 2% 4
4 CHEMOTHERAPY INDUCED LEUKOPENIA 3 42% 2% 5
5 AML CELLS 3 18% 6% 13
6 CONSTITUTIVE CHEMOKINE RELEASE 2 67% 1% 2
7 CONSTITUTIVE CYTOKINE SECRETION 2 67% 1% 2
8 INVITRO PROLIFERATION 2 29% 3% 6
9 INDUCED LEUKOPENIA 2 21% 3% 7
10 FLT3 ABNORMALITIES 1 50% 1% 2

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
New strategies in the treatment of acute myelogenous leukemia (AML): In vitro culture of AML cells - The present use in experimental studies and the possible importance for future therapeutic approaches 2001 35 70 21%
The Chemokine System in Experimental and Clinical Hematology 2010 14 21 24%
The Possible Diagnostic and Prognostic Use of Systemic Chemokine Profiles in Clinical Medicine-The Experience in Acute Myeloid Leukemia from Disease Development and Diagnosis via Conventional Chemotherapy to Allogeneic Stem Cell Transplantation 2013 4 118 24%
The Chemokine Network in Acute Myelogenous Leukemia: Molecular Mechanisms Involved in Leukemogenesis and Therapeutic Implications 2010 13 108 19%
The angioregulatory cytokine network in human acute myeloid leukemia - from leukemogenesis via remission induction to stem cell transplantation 2012 6 134 16%
IL-4, IL-10 and IL-13 in acute myelogenous leukemia 1998 14 117 19%
Bidirectional crosstalk between platelets and monocytes initiated by Toll-like receptor: An important step in the early defense against fungal infections? 2013 6 114 11%
Anticancer Immunotherapy in Combination with Proapoptotic Therapy 2008 8 67 15%
Serum levels of adhesion molecules and cytokines in patients with acute leukaemia 1996 13 40 10%
Biological treatment in acute myelogenous leukaemia: how should cell targeting immunotherapy be combined with intensive chemotherapy? 2001 16 104 13%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 ASL CASERTA CE 1 50% 0.5% 1
2 COE DEV BIOL REGENERAT MED CEDB DBRM 1 50% 0.5% 1
3 GRC 07 1 50% 0.5% 1
4 INFECT DIS EMPLOYEE HLTH 1 50% 0.5% 1
5 NAGANO 1 50% 0.5% 1
6 INTERNAL MED HEMATOL 4 1 19% 1.4% 3
7 U 774 0 33% 0.5% 1
8 BIOMED SCI CHEM ENGN 0 25% 0.5% 1
9 GENOSPLICE 0 25% 0.5% 1
10 UNIT 774 0 25% 0.5% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000220608 PRAME//LEUKEMIA ASSOCIATED ANTIGENS//UNIT 900
2 0.0000203963 ADAPHOSTIN//BONE MARROW MICROVESSEL DENSITY//PEDIAT PEDIAT ONCOL HEMATOL
3 0.0000161691 LEUKEMIC BLAST PROGENITORS//L CFU//500 SHERBOURNE ST
4 0.0000125439 ENDOCAN//ESM 1//ENDOTHELIAL CELL SPECIFIC MOLECULE 1
5 0.0000113053 MHC NONRESTRICTED CYTOTOXICITY//HISTAMINE DIHYDROCHLORIDE//BOWYER ONCOL
6 0.0000078657 LYMPHOCYTE RECOVERY//IMMUNE RECONSTITUTION//BMT RECIPIENTS
7 0.0000077968 LEUKEMIA STEM CELLS//EXPT THER EUT TRANSLAT ONCOL PROGRAM//LEUKEMIC STEM CELL
8 0.0000074360 CHROMOSOME 5 ABNORMALITY//PHARM NTHC NARILIS//UNIDAD HEMATOL CLIN
9 0.0000073301 ACUTE MYELOID LEUKEMIA//GEMTUZUMAB OZOGAMICIN//AML
10 0.0000072918 FLT3//FLT3 ITD//NPM1